Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 723 Neoplasms 461 Prostatic Neoplasms 398 Carcinoma, Non-Small-Cell Lung 387 Lung Neoplasms 310 Leukemia, Myeloid, Acute 301 Multiple Myeloma 270 Colorectal Neoplasms 243 Neoplasm Metastasis 240 Pancreatic Neoplasms 238 Leukemia 235 Melanoma 217 Lymphoma 213 Precursor Cell Lymphoblastic Leukemia-Lymphoma 204 Brain Neoplasms 195 Recurrence 178 Head and Neck Neoplasms 177 Lymphoma, Non-Hodgkin 174 Leukemia, Lymphocytic, Chronic, B-Cell 168 Myelodysplastic Syndromes 167 Ovarian Neoplasms 160 Carcinoma, Hepatocellular 154 Glioblastoma 149 Carcinoma, Renal Cell 137 Rectal Neoplasms 134 Colonic Neoplasms 129 Lymphoma, Large B-Cell, Diffuse 125 Lymphoma, Follicular 125 Hodgkin Disease 116 Squamous Cell Carcinoma of Head and Neck 109

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × Resectable Esophageal Cancer × Clear all

NCT00827671 2018-03-09

TRACC

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡